Pell Bio-Med Technology Co., Ltd. (TPE:6949)
Taiwan · Delayed Price · Currency is TWD 658.00
+13.00 (2.02%)
Jun 5, 2026, 1:30 PM CST
Pell Bio-Med Technology Market Cap
Pell Bio-Med Technology has a market cap or net worth of 41.74 billion as of June 5, 2026. Its market cap has increased by 474.98% in one year.
Market Cap
41.74B
Enterprise Value
39.79B
Revenue
25.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
658.00
Market Cap Chart
Since March 8, 2024, Pell Bio-Med Technology's market cap has increased from 5.56B to 41.74B, an increase of 651.29%. That is a compound annual growth rate of 145.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2026 | 41.74B | 108.07% |
| Dec 31, 2025 | 20.06B | 324.81% |
| Dec 31, 2024 | 4.72B | -15.00% |
| Mar 8, 2024 | 5.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 150.19B |
| Lin BioScience | 31.56B |
| Oneness Biotech | 24.54B |
| Sunmax Biotechnology | 20.67B |
| Lumosa Therapeutics | 19.76B |
| Medigen Vaccine Biologics | 14.81B |
| CHO Pharma | 14.55B |
| TaiMed Biologics | 14.40B |